Siegfried Detailed Consensus >> Group
Consensus as of: 2024-03-13

KPI[CHF m]H1 2023H2 2023FY 2023H1 2024 EH2 2024 EFY 2024 EFY 2025 EFY 2026 E
Net Sales totalNumber of Estimates55111111
Net Sales totalHighest6137001,3301,4501,563
Net Sales totalConsensus (Mean)6076641,2726046941,3011,4021,510
Net Sales totalMedian6106941,3011,4001,509
Net Sales totalLowest5886901,2801,3651,451
Net Sales Drug Substances Number of Estimates55101010
Net Sales Drug Substances Highest4114969159791,049
Net Sales Drug Substances Consensus (Mean)3994628604064888969641,032
Net Sales Drug Substances Median4084858979641,036
Net Sales Drug Substances Lowest399483859942998
Net Sales Drug Products Number of Estimates55101010
Net Sales Drug Products Highest206216436471515
Net Sales Drug Products Consensus (Mean)209203412197206406440479
Net Sales Drug Products Median203207408443482
Net Sales Drug Products Lowest177198368402439
Growth at CER Number of Estimates55988
Growth at CER Highest3.86.77.19.38.7
Growth at CER Consensus (Mean)6.8-6.32.15.43.97.37.6
Growth at CER Median2.65.23.47.17.9
Growth at CER Lowest0.04.32.46.06.3
Gross Profit Number of Estimates55111111
Gross Profit Highest153186363383435
Gross Profit Consensus (Mean)148173320150180336369403
Gross Profit Median150180333370402
Gross Profit Lowest149176326354387
SG&A Number of Estimates55101010
SG&A Highest-43-22-71-73-76
SG&A Consensus (Mean)-49-59-109-47-45-96-101-107
SG&A Median-48-50-96-102-107
SG&A Lowest-50-59-109-116-123
EBIT Number of Estimates55111111
EBIT Highest88129214238268
EBIT Consensus (Mean)829017285118201227254
EBIT Median85115199226254
EBIT Lowest84107190218244
Core EBITNumber of Estimates55999
Core EBITHighest90125216241266
Core EBITConsensus (Mean)8710519287114203227252
Core EBITMedian88116202226249
Core EBITLowest85107195218244
EBITDA Number of Estimates55101010
EBITDA Highest130176300330366
EBITDA Consensus (Mean)121133253126163287320355
EBITDA Median124160287322355
EBITDA Lowest124152276308347
Core EBITDA Number of Estimates55111111
Core EBITDA Highest130168302328364
Core EBITDA Consensus (Mean)126148273128159288320353
Core EBITDA Median129160289322354
Core EBITDA Lowest125152278307339
Taxes Number of Estimates55111111
Taxes Highest-17-22-39-44-46
Taxes Consensus (Mean)-20-18-38-19-25-43-47-51
Taxes Median-19-25-44-47-51
Taxes Lowest-20-28-47-52-55
Net Income Number of Estimates55111111
Net Income Highest6395156180209
Net Income Consensus (Mean)55581136087147170194
Net Income Median6287147171192
Net Income Lowest5179139166186
Core Net Income Number of Estimates55888
Core Net Income Highest6492157182205
Core Net Income Consensus (Mean)59691286186148170191
Core Net Income Median6186147168190
Core Net Income Lowest5678139161184
EPS diluted Number of Estimates55111111
EPS diluted Highest14.7722.1836.8042.3849.38
EPS diluted Consensus (Mean)12.99-26.2213.9720.3134.1139.5944.98
EPS diluted Median14.2820.1434.0839.2944.30
EPS diluted Lowest11.9318.0432.1438.0842.11
Core EPS diluted Number of Estimates55888
Core EPS diluted Highest15.1521.8036.9142.9548.27
Core EPS diluted Consensus (Mean)13.84-29.8014.2719.9934.5339.5144.47
Core EPS diluted Median14.1120.2834.1138.7243.94
Core EPS diluted Lowest13.1717.9031.9937.8141.83
Dividend Number of Estimates--111111
Dividend Highest--4.004.505.00
Dividend Consensus (Mean)--3.60--3.834.074.35
Dividend Median--3.804.004.20
Dividend Lowest--3.804.004.20
Cash flow from Operations Number of Estimates44111111
Cash flow from Operations Highest130143316286292
Cash flow from Operations Consensus (Mean)79130209107124245243263
Cash flow from Operations Median110119245230268
Cash flow from Operations Lowest79114173222246
CapEx (excluding acquisitions) Number of Estimates44111111
CapEx (excluding acquisitions) Highest-70-95-180-145-141
CapEx (excluding acquisitions) Consensus (Mean)-65-63-127-86-105-190-170-170
CapEx (excluding acquisitions) Median-88-105-193-171-165
CapEx (excluding acquisitions) Lowest-100-113-200-196-197
Disclaimer

This document has been issued by Vara Research GmbH for information purposes only and is not intended to constitute investment advice. It is based on estimates and forecasts of various analysts regarding revenues, earnings and business developments of the relevant company. The company did not participate in the compilation of the estimates and it does not endorse them. Such estimates and forecasts cannot be independently verified by reason of the subjective character. Vara Research GmbH gives no guarantee, representation or warranty and is not responsible or liable as to its accuracy and completeness.